Kronox Lab Sciences Limited is an India-based company engaged in the manufacturing of high purity fine, inorganic chemicals, phosphate and metallic chemicals. It is a bulk manufacturer of high purity fine chemicals for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis and other specialty markets. The Company offers a line of chemicals including acetates, carbonates, chlorides, citrates, nitrates, nitrites, phosphates, sulfates, and ultrapure metallic salts. The Company’s product range includes ACS Reagent, LR, AR and GR Reagents, Oral Care, Pharmacopoeia, Food and Nutraceutical, Personal Care and Cosmetics, Veterinary Pharma and Animal Health, Tartrates, Citrates, Hypophosphites, Phosphates, Hydroxides, Ethylenediaminetetraacetic acid (EDTA) and Derivatives, Ultra High Purity Chemicals, Custom Specification, and Specialty Anhydrous. It manufactures high purity specialty fine chemicals of various grades in particle sizes ranging from 10 mesh to 100 mesh.
KRONOX LAB SCIENCES LTD Financial Highlights
- Revenue: KRONOX LAB SCIENCES LTD reported revenue of ₹106.41 crore in FY26 vs ₹102.72 crore in FY25. It showed an increase of 3.59% on a yearly basis.
- Operating Profit: KRONOX LAB SCIENCES LTD reported an operating profit of ₹37.30 crore in FY26 vs ₹34.27 crore in FY25. It showed an increase of 8.84% on a year-on-year basis.
- Net Profit: KRONOX LAB SCIENCES LTD reported a net profit of ₹27.66 crore in FY26 vs ₹25.47 crore in FY25. It showed an increase of 8.60% on a yearly basis.
KRONOX LAB SCIENCES LTD Quarterly Result Highlights
- KRONOX LAB SCIENCES LTD reported revenue of ₹28.28 crore in Mar 2026, compared with ₹26.40 crore in Dec 2025, representing an increase of 7.12% on a quarter-on-quarter (QoQ) basis.
- KRONOX LAB SCIENCES LTD reported an operating profit of ₹10.97 crore in Mar 2026, compared with ₹8.60 crore in Dec 2025, representing an increase of 27.56% on a quarter-on-quarter (QoQ) basis.
- KRONOX LAB SCIENCES LTD reported a profit of ₹8.00 crore in Mar 2026, compared with ₹6.59 crore in Dec 2025, reflecting an increase of 21.40% on a QoQ basis.
- The earnings per share (EPS) of KRONOX LAB SCIENCES LTD stood at ₹6.91 during Mar 2026.